Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.

MLA

Wang, Pengyu, et al. “Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.” Biology (2079-7737), vol. 13, no. 8, Aug. 2024, p. 597. EBSCOhost, https://doi.org/10.3390/biology13080597.

APA

Wang, P., Lan, Q., Huang, Q., Zhang, R., Zhang, S., Yang, L., Song, Y., Wang, T., Ma, G., Liu, X., Guo, X., Zhang, Y., & Liu, C. (2024). Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology (2079-7737), 13(8), 597. https://doi.org/10.3390/biology13080597

Chicago

Wang, Pengyu, Qing Lan, Qi Huang, Ruyi Zhang, Shuo Zhang, Leiming Yang, Yan Song, et al. 2024. “Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.” Biology (2079-7737) 13 (8): 597. doi:10.3390/biology13080597.